|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
1
|
Resverlogix Corp.
|
Jan 09, 2019 09:35AM
|
|
Re: ZE Slides Up
|
5
|
Zenith Epigenetics
|
Jan 08, 2019 06:06PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
2
|
Resverlogix Corp.
|
Jan 08, 2019 05:49PM
|
|
Re: Bioasis To Present at Investor & Industry Conferences in January 2019
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 08, 2019 11:30AM
|
|
Re: Biotech Showcase
|
3
|
Zenith Epigenetics
|
Jan 08, 2019 11:15AM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
3
|
Resverlogix Corp.
|
Jan 08, 2019 10:21AM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
2
|
Resverlogix Corp.
|
Jan 08, 2019 09:12AM
|
|
Re: Biotech Showcase Presentation is up
|
3
|
Resverlogix Corp.
|
Jan 07, 2019 10:17PM
|
|
Biotech Showcase Presentation is up
|
2
|
Resverlogix Corp.
|
Jan 07, 2019 08:08PM
|
|
Re: Bioasis announces a joint research collaboration with a leading pharmaceutical company.
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jan 07, 2019 09:07AM
|
|
Re: Revamped website
|
5
|
Resverlogix Corp.
|
Jan 06, 2019 09:46PM
|
|
Re: Revamped website
|
5
|
Resverlogix Corp.
|
Jan 06, 2019 09:35PM
|
|
Re: Revamped website
|
4
|
Resverlogix Corp.
|
Jan 06, 2019 07:35AM
|
|
Revamped website
|
4
|
Resverlogix Corp.
|
Jan 05, 2019 11:53AM
|
|
Re: Share Price
|
4
|
Resverlogix Corp.
|
Jan 04, 2019 12:07PM
|
|
Phase 1b/2 trial expected to initiate 1Q 2019
|
7
|
Zenith Epigenetics
|
Jan 04, 2019 10:51AM
|
|
Re: Shares to Zenith
|
4
|
Resverlogix Corp.
|
Jan 03, 2019 10:15PM
|
|
Re: Zacks SCR Resverlogix Report 12/28/18
|
5
|
Resverlogix Corp.
|
Jan 02, 2019 12:32PM
|
|
Zacks SCR Resverlogix Report 12/28/18
|
3
|
Resverlogix Corp.
|
Jan 02, 2019 11:57AM
|
|
Re: 2019 Potential Events
|
3
|
Resverlogix Corp.
|
Jan 02, 2019 11:23AM
|
